Results after isolated aortic valve replacement with bileaflet prostheses in patients over 70 years old were reviewed.
One-hundred-twenty-eight elderly patients were operated on between January 1988 and January 2000. Patients with associated heart disease were excluded from the study. Preoperative data, early and late postoperative mortality, all valve related complications and data concerning anticoagulation status were recorded.
Hospital mortality was 9.3%. Mean follow-up time was 60.98±2.23 months. Twelve-year actuarial survival was 69.6±0.08%. Valve related and anticoagulation related complication rates (0.8% and 1.6% respectively) and actuarial freedom (99±0.009 both) were low, as well as the mean interval between consecutive INR checks (18.39±1.90 days) and the mean INR value (2.17±0.135). Late echocardiographic results showed low postoperative mean transprosthetic gradients (15.48±0.94).
Bileaftlet prostheses in the elderly can achieve excellent results with a low incidence of anticoagulation related complications and low risk of reoperation. Older age can no longer be considered a contraindication to bileaftlet prosthesis implant.
JamiesonW.R.E.. Mechanical and bioprosthetic aortic valve replacement. In: EdmundsL.H.Jr., ed. Cardiac surgery in the adult.New York: McGraw-Hill, 1997: 859–909.
2.
EdmundsL.H.Jr., ClarkR.E., CohnL.H., MillerD.C., WeiselR.D.. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg1996; 62: 932–5.
3.
Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Lancet1994; 343: 687–91.
4.
Van der MeerF.J., RosendaalF.R., VandenbrouckeJ.P., BriefE.. Bleeding complications in oral anticoagulant therapy. A n analysis of risk factors. Arch Intern Med1989; 225: 137–42.
5.
FihnS.D., CallahanC.M., MartinD.C., McDonellM.B., HenikoffJ.G., WhiteR.H.. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med1996; 124: 970–9.
6.
MasterR.G., SemelhagoL.C., PipeA.L., KeonW.J.. Are older patients with mechanical heart valves at increased risk?Ann Thorac Surg1999; 68: 2169–72.
7.
Van NootenG., CaesF., FrancoisK., Van BelleghemY., TaeymansY.. Stentless or stented aortic valve implants in elderly patients?Eur J Cardiothorac Surg1999; 15: 31–6.
8.
HolperK., WottkeM., LeweT.Bioprosthetic and mechanical valves in the elderly: benefits and risks. Ann Thorac Surg1995; 60(suppl.): S443–6.
9.
BorkonA.M., SouleL.M., BaugmanK.L.Aortic valve selection in the elderly patient. Ann Thorac Surg1988; 46: 270–7.
10.
AromK.V., EmeryR.W., NicoloffD.M., PetersenR.J.. Anticoagulant related complications in elderly patients with St. Jude mechanical valve prostheses. J Heart Valve Dis1996; 5: 505–10.
11.
YamakB., KaragozHy, ZorlutunaY., EralpA., TasdemirO., BayazitK.. Low-dose anticoagulant management of patients with St. Jude medical mechanical valve prostheses. Thorac Cardiovasc Surg1993; 41: 38–42.
12.
LogeaisY., LanganayT., CorbineauH., RoussinR., RiouxC., LeguerrierA.. Aortic valve replacement in the elderly: bioprosthesis or mechanical valve?Ann Thorac Surg1998; (suppl 6): S77–81.
13.
DavisE.A., GreeneP.S., CameronD.E.Bioprosthetic versus mechanical prostheses for aortic valve replacement in the elderly. Circulation1996; (suppl 9) P II: 121–5.
14.
ChambersJ., FraserA., LawfordP., NihoyannopoulosP., SimpsonI.. Echocardiographic assessment of artificial heart valves: British Society of Echocardiography position paper, Br Heart J1994; 71(suppl. 4): S6–14.
15.
ChamberJ., ShahP.M.. Recommendations for the echocardiographic assessment of replacement heart valves. J Heart Valve Dis1995; 4: 9–13.
16.
Draft: Replacement heart valve guidance.United States Food & Drug Administration, Version 4.1, 1994.
17.
SahnD.J., DeMariaA., KissloJ., WeymanA.E.. Recommendation regarding quantitation in M-mode echocardiography; results of a survey of echocardiographic measurements. (Standard M-mode dimensions utilizing the American Society of Echocardiography). Circulation1978; 58: 1072.
18.
NinetJ., TroncF., RobinJ., CurtilA., AleksicI., ChampsaurG.. Mechanical versus biological isolated aortic valvular replacement after the age of 70: equivalent long-term results. Eur J Cardiothorac Surg1998; 1: 84–9.
19.
MilanoA., GuglielminiC., De CarloM.Valve-related complications in elderly patients with biological and mechanical aortic valves. Ann Thorac Surg1998; 66(suppl. 6): S82–7.
20.
VitaleN., GiannoloB., NappiG.A.Long-term follow-up of different models of mechanical and biological mitral prostheses. Eur J Cardiothorac Surg1995; 9: 181–9.
21.
TyersG.F.O., JamiesonW.R.E., MunroA.I.Reoperation in biological and mechanical valve populations: fate of the reoperative patient. Ann Thorac Surg1995; 60(suppl.): S464–9.
22.
SawantD., SinghA.K., FengW.C., BertA.A., RotenbergF.. Ninteen-millimeter aortic St Jude mechanical heart valve prosthesis: up to sixteen years follow-up. Ann Thorac Surg1997; 63: 964–70.
23.
RenzulliA., IsmenoG., BellittiR.Long-term results of heart valve replacement with bileaflet prostheses. J Cardiovasc Surg1997; 38: 241–7.
24.
LandefeldC.S., GoldmanL.. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med1989; 87: 144–52.
25.
LundstromT., RydenL.. Haemorragic and thromboembolic complications in patients with atrial fibrillation on anticoagulant profilaxis. J Intern Med1989; 225: 137–42.
26.
HorstkotteD., PiperC., WiemerM.. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis1998; (suppl 1): S19–24.
